Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
The global average gross margin of Gastrointestinal is in a slight decreasing trend, and the gross margin is 63% in 2015.
Europe region is the largest supplier of Gastrointestinal, with a production revenue market share nearly 50% in 2015. North America is the second largest supplier of Gastrointestinal, enjoying production revenue market share nearly 22% in 2015.
North America is the largest consumption place, with a consumption value market share nearly 52% in 2015. Following North America, Europe is the second largest consumption place with the consumption value market share of 22% in 2015.
Market competition is intense. AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. are the leaders of the industry, and they hold high-end customers, and their products are famous in the world.
With the development of economic, more and more companies participate in this industry with their new type products.
Over the next five years, LPI(LP Information) projects that Gastrointestinal will register a 0.9% CAGR in terms of revenue, reach US$ 35300 million by 2023, from US$ 33600 million in 2017.
This report studies the global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players:
- AstraZenec
- Sanofi
- Bayer
- Pfizer
- GlaxoSmithKline
- Teva
- Zeria(Tillotts)
- Perrigo
- Boehringer Ingelheim
- Purdue Pharma
- C.B. Fleet
- Abbott
- Jiangzhong
- Xian-Janssen
Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top players in these regions, from 2013 to 2018 (forecast), like
- North America (United States, Canada and Mexico)
- Asia-Pacific (China, Japan, Southeast Asia, India and Korea)
- Europe (Germany, UK, France, Italy and Russia etc.)
- South America (Brazil, Chile, Peru and Argentina)
- Middle East and Africa (Egypt, South Africa, Saudi Arabia)
Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
- Prescription Gastrointestinal Drug
- OTC Gastrointestinal Drug
Split by applications, this report focuses on sales, market share and growth rate in each application, can be divided into
- Chronic Gastritis
- Functional Dyspepsia
- Peptic Ulcer
- Acute Gastroenteritis
- Other